NO20081690L - Tumorassosierte peptider som bindes til humant leukocyttantigen (HLA) klasse I- eller II-molekyler og relatert vaksine mot kreft - Google Patents
Tumorassosierte peptider som bindes til humant leukocyttantigen (HLA) klasse I- eller II-molekyler og relatert vaksine mot kreftInfo
- Publication number
- NO20081690L NO20081690L NO20081690A NO20081690A NO20081690L NO 20081690 L NO20081690 L NO 20081690L NO 20081690 A NO20081690 A NO 20081690A NO 20081690 A NO20081690 A NO 20081690A NO 20081690 L NO20081690 L NO 20081690L
- Authority
- NO
- Norway
- Prior art keywords
- molecules
- tumour
- present
- relates
- hla
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05019255A EP1760089B1 (fr) | 2005-09-05 | 2005-09-05 | Peptides associés aux tumeurs, qui s'attachent à l'antigène leucocitaire humaine (HLA) classe I ou II et vaccins anti-tumoraux associés |
| PCT/EP2006/008641 WO2007028573A1 (fr) | 2005-09-05 | 2006-09-05 | Peptides associes aux tumeurs se liant aux molecules d'antigene de leucocyte humain (hla) de classe i ou ii et vaccin contre le cancer associe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20081690L true NO20081690L (no) | 2008-04-04 |
Family
ID=35149455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081690A NO20081690L (no) | 2005-09-05 | 2008-04-04 | Tumorassosierte peptider som bindes til humant leukocyttantigen (HLA) klasse I- eller II-molekyler og relatert vaksine mot kreft |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20090274714A1 (fr) |
| EP (2) | EP1760089B1 (fr) |
| JP (1) | JP5132561B2 (fr) |
| KR (1) | KR101150663B1 (fr) |
| CN (1) | CN101287755B (fr) |
| AT (2) | ATE440107T1 (fr) |
| AU (1) | AU2006289289B2 (fr) |
| BR (1) | BRPI0615466A2 (fr) |
| CA (1) | CA2621414C (fr) |
| CY (2) | CY1110536T1 (fr) |
| DE (2) | DE602005016112D1 (fr) |
| DK (2) | DK1760089T3 (fr) |
| EA (1) | EA013466B1 (fr) |
| ES (2) | ES2330013T3 (fr) |
| HR (1) | HRP20110240T1 (fr) |
| NO (1) | NO20081690L (fr) |
| NZ (1) | NZ565956A (fr) |
| PL (2) | PL1760089T3 (fr) |
| PT (2) | PT1760089E (fr) |
| RS (1) | RS51893B (fr) |
| SI (2) | SI1760089T1 (fr) |
| UA (2) | UA97095C2 (fr) |
| WO (1) | WO2007028573A1 (fr) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE461214T1 (de) * | 2005-09-05 | 2010-04-15 | Immatics Biotechnologies Gmbh | Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden |
| US20090004213A1 (en) | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| ES2321680B1 (es) * | 2007-04-26 | 2010-03-05 | Fundacion Para La Investigacion Biosanitaria De Andalucia Oriental - Alejandro Otero (Fibao) | Restauracion de las moleculas hla de clase i mediante terapia genica empleando vectores adenovirales portando el gen de la beta 2-microglobulina. |
| UA103882C2 (uk) * | 2007-07-27 | 2013-12-10 | Імматікс Біотекнолоджіс Гмбх | Композиція пухлино-асоційованих пептидів та відповідна протиракова вакцина |
| HUE025636T2 (en) * | 2007-07-27 | 2016-04-28 | Immatics Biotechnologies Gmbh | New immunogenic epitope for immunotherapy |
| KR101290892B1 (ko) | 2007-07-27 | 2013-07-31 | 이매틱스 바이오테크놀로지스 게엠베하 | 신경 및 뇌 종양에 대한 신규 면역요법 |
| CY1112212T1 (el) * | 2008-04-24 | 2015-12-09 | Immatics Biotechnologies Gmbh | Νεα σκευασματα πεπτιδιων που σχετιζονται με ογκους τα οποια συνδεονται σε μορια του αντιγονου ανθρωπινων λευκοκυτταρων (hla) ταξης i ή ii για εμβολια |
| ATE462442T1 (de) | 2008-04-30 | 2010-04-15 | Immatics Biotechnologies Gmbh | Neuartige formulierungen von tumor-assoziierten peptiden, welche an menschliche leukozytenantigene der klasse i oder ii für impfungen binden |
| EP2119726B2 (fr) | 2008-05-14 | 2017-11-29 | Immatics Biotechnologies GmbH | Nouveaux peptides puissants de classe II-MHC dérivés de la survivine et neurocane |
| AU2016204711B2 (en) * | 2008-10-01 | 2018-03-01 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors including neuronal and brain tumors |
| DK2172211T3 (en) * | 2008-10-01 | 2015-02-16 | Immatics Biotechnologies Gmbh | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| GB201004551D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| GB201004575D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| GB201006360D0 (en) * | 2010-04-16 | 2010-06-02 | Immatics Biotechnologies Gmbh | Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
| GB201009222D0 (en) * | 2010-06-02 | 2010-07-21 | Immatics Biotechnologies Gmbh | Improved cancer therapy based on tumour associated antigens derived from cyclin D1 |
| SG10201509823WA (en) * | 2010-12-02 | 2015-12-30 | Oncotherapy Science Inc | TOMM34 Peptides And Vaccines Including The Same |
| RU2607379C2 (ru) * | 2011-07-05 | 2017-01-10 | Кадила Фармасьютикалз Лимитед | Раковый антиген |
| MY170949A (en) * | 2011-07-11 | 2019-09-20 | Cancer Res Initiatives Foundation | A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine |
| CN104662170A (zh) | 2012-06-27 | 2015-05-27 | 新泽西鲁特格斯州立大学 | 通过使用流式细胞术的rna测量快速检测t细胞活化 |
| US20140017267A1 (en) * | 2012-07-13 | 2014-01-16 | Matthias W Rath | Metalloproteinase oligopeptides and their therapeutic use |
| TWI819228B (zh) * | 2013-08-05 | 2023-10-21 | 德商伊瑪提克斯生物科技有限公司 | 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物（八） |
| JP6781403B2 (ja) | 2013-12-09 | 2020-11-04 | タルゴバックス エーエスエー | ペプチド混合物 |
| GB201501017D0 (en) | 2014-12-23 | 2015-03-04 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers |
| HUE056607T2 (hu) | 2014-12-23 | 2022-02-28 | Immatics Biotechnologies Gmbh | Új peptidek és peptidkombinációk, hepatocelluláris karcinóma (HCC) és más rákok elleni immunoterápiában történõ alkalmazásra |
| EP3271382B1 (fr) * | 2015-03-16 | 2020-02-12 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | Procédé de détection de nouveaux épitopes de lymphocytes t immunogènes et isolement de nouveaux récepteurs de lymphocytes t spécifiques d'antigène au moyen d'une banque de cellules du complexe majeur d'histocompatibilité (cmh) |
| TWI755157B (zh) | 2015-03-17 | 2022-02-11 | 德商英麥提克生物技術股份有限公司 | 用於抗胰臟癌與其他癌症的免疫治療的新穎胜肽及胜肽的組合 |
| GB201504502D0 (en) * | 2015-03-17 | 2015-04-29 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers |
| PT3388075T (pt) | 2015-03-27 | 2023-08-18 | Immatics Biotechnologies Gmbh | Novos péptidos e combinações de péptidos para uso em imunoterapia contra vários tumores |
| GB201505305D0 (en) | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| GB201505585D0 (en) * | 2015-03-31 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers |
| GB201507030D0 (en) * | 2015-04-24 | 2015-06-10 | Immatics Biotechnologies Gmbh | Immunotherapy against lung cancers, in particular NSCLC |
| GB201510771D0 (en) | 2015-06-19 | 2015-08-05 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer |
| CN113563455A (zh) | 2015-06-19 | 2021-10-29 | 伊玛提克斯生物技术有限公司 | 用于免疫治疗的新型肽和肽组合物以及用于胰腺癌和其他癌症的支架产生方法 |
| ZA201707555B (en) | 2015-06-25 | 2018-11-28 | Immatics Biotechnologies Gmbh | Novel cell epitopes and combination of cell epitopes for use in the immuno-therapy of myeloma and other cancers |
| GB201511191D0 (en) | 2015-06-25 | 2015-08-12 | Immatics Biotechnologies Gmbh | T-cell epitopes for the immunotherapy of myeloma |
| GB201511546D0 (en) | 2015-07-01 | 2015-08-12 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| PE20230321A1 (es) * | 2015-07-01 | 2023-02-22 | Immatics Biotechnologies Gmbh | Nuevos peptidos y nuevas combinaciones de peptidos para el uso en la inmunoterapia contra el cancer de ovario y otros tipos de cancer |
| CN107912043B (zh) | 2015-07-06 | 2022-02-18 | 伊玛提克斯生物技术有限公司 | 用于食管癌和其他癌症免疫治疗的新型肽和肽组合物 |
| GB201511792D0 (en) | 2015-07-06 | 2015-08-19 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers |
| GB201512369D0 (en) * | 2015-07-15 | 2015-08-19 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers |
| GB201517538D0 (en) | 2015-10-05 | 2015-11-18 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| MY198087A (en) | 2015-10-05 | 2023-07-31 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| EP3167898A1 (fr) | 2015-11-11 | 2017-05-17 | IEO - Istituto Europeo di Oncologia Srl | Procédé d'obtention de peptides de tumeur et leurs utilisations |
| US20190070275A1 (en) * | 2016-02-22 | 2019-03-07 | Oceanside Biotechnology | Neoantigen compositions and methods of using the same in immunooncotherapy |
| EP3436048A4 (fr) * | 2016-03-31 | 2019-11-27 | Neon Therapeutics, Inc. | Néoantigènes et leurs procédés d'utilisation |
| TWI796299B (zh) * | 2016-08-26 | 2023-03-21 | 德商英麥提克生物技術股份有限公司 | 用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架 |
| NZ754222A (en) | 2016-12-08 | 2022-02-25 | Immatics Biotechnologies Gmbh | T cell receptors with improved pairing |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| CN106986932A (zh) * | 2017-04-06 | 2017-07-28 | 海口市人民医院 | 一种c‑Met表位肽及其应用 |
| CN111788214B (zh) * | 2018-02-15 | 2021-06-22 | 国立大学法人旭川医科大学 | 癌症抗原肽 |
| CN110804642B (zh) * | 2019-09-10 | 2022-06-21 | 清华大学 | Gpr174免疫学功能及其用途 |
| WO2021096446A1 (fr) * | 2019-11-14 | 2021-05-20 | Bogazici Universitesi | Taches asc utilisées en immunothérapie anticancéreuse |
| CN114524870A (zh) * | 2020-11-23 | 2022-05-24 | 香雪生命科学技术（广东）有限公司 | 源自于ssx2抗原的短肽 |
| EP4326325A1 (fr) * | 2021-04-23 | 2024-02-28 | Flow Pharma Inc. | Vaccin anti-sars-cov-2 |
| CN114478711A (zh) * | 2022-01-05 | 2022-05-13 | 成都朗谷生物科技股份有限公司 | 一种针对乙型肝炎病毒的抗原肽及其应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4440859A (en) | 1977-05-27 | 1984-04-03 | The Regents Of The University Of California | Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms |
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| NZ192465A (en) | 1978-12-22 | 1983-09-30 | Biogen Nv | Recombinant dna molecule comprising gene coding for polypeptide displaying hbv (hepatitis b virus) antigenicity usesthereof |
| US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| US4678751A (en) | 1981-09-25 | 1987-07-07 | Genentech, Inc. | Hybrid human leukocyte interferons |
| US4766075A (en) | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
| US4582800A (en) | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US4677063A (en) | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| US4810648A (en) | 1986-01-08 | 1989-03-07 | Rhone Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the gene |
| CA2142007C (fr) * | 1992-08-11 | 2007-10-30 | Robert Glen Urban | Peptides immunomodulateurs |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| CN1180843C (zh) | 1994-07-27 | 2004-12-22 | 昆士兰医学研究所 | 多表位疫苗 |
| US6805861B2 (en) | 1996-01-17 | 2004-10-19 | Imperial College Innovations Limited | Immunotherapy using cytotoxic T lymphocytes (CTL) |
| US6096313A (en) * | 1996-02-09 | 2000-08-01 | Ludwig Institute For Cancer Research | Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| US6316213B1 (en) * | 1997-03-19 | 2001-11-13 | The Board Of Trustees Of The University Of Arkansas | Methods for the early diagnosis of ovarian, breast and lung cancer |
| IL125608A0 (en) * | 1998-07-30 | 1999-03-12 | Yeda Res & Dev | Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| DE19917195B4 (de) | 1999-04-16 | 2006-09-28 | Immatics Biotechnologies Gmbh | Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor |
| KR100358068B1 (ko) * | 1999-12-28 | 2002-10-25 | 주식회사 하이닉스반도체 | 플래쉬 메모리 소자의 제조방법 |
| WO2004014867A2 (fr) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Inhibiteurs de metalloproteinases matricielles et procedes d'identification de tetes de serie |
| US20060045881A1 (en) * | 2004-08-26 | 2006-03-02 | Board Of Regents, The University Of Texas System | Anti-cancer vaccines |
-
2005
- 2005-09-05 AT AT05019255T patent/ATE440107T1/de active
- 2005-09-05 ES ES05019255T patent/ES2330013T3/es active Active
- 2005-09-05 SI SI200530796T patent/SI1760089T1/sl unknown
- 2005-09-05 DE DE602005016112T patent/DE602005016112D1/de active Active
- 2005-09-05 DK DK05019255T patent/DK1760089T3/da active
- 2005-09-05 EP EP05019255A patent/EP1760089B1/fr not_active Not-in-force
- 2005-09-05 PT PT05019255T patent/PT1760089E/pt unknown
- 2005-09-05 PL PL05019255T patent/PL1760089T3/pl unknown
-
2006
- 2006-09-05 DE DE602006019446T patent/DE602006019446D1/de active Active
- 2006-09-05 KR KR1020087008126A patent/KR101150663B1/ko not_active IP Right Cessation
- 2006-09-05 ES ES06777167T patent/ES2358802T3/es active Active
- 2006-09-05 US US12/065,725 patent/US20090274714A1/en not_active Abandoned
- 2006-09-05 CA CA2621414A patent/CA2621414C/fr not_active Expired - Fee Related
- 2006-09-05 EP EP06777167A patent/EP1922334B1/fr active Active
- 2006-09-05 SI SI200630949T patent/SI1922334T1/sl unknown
- 2006-09-05 EA EA200800676A patent/EA013466B1/ru not_active IP Right Cessation
- 2006-09-05 UA UAA200803781A patent/UA97095C2/ru unknown
- 2006-09-05 WO PCT/EP2006/008641 patent/WO2007028573A1/fr active Application Filing
- 2006-09-05 JP JP2008528437A patent/JP5132561B2/ja not_active Expired - Fee Related
- 2006-09-05 CN CN200680038407.7A patent/CN101287755B/zh not_active Expired - Fee Related
- 2006-09-05 PL PL06777167T patent/PL1922334T3/pl unknown
- 2006-09-05 DK DK06777167.5T patent/DK1922334T3/da active
- 2006-09-05 PT PT06777167T patent/PT1922334E/pt unknown
- 2006-09-05 RS RS20110146A patent/RS51893B/en unknown
- 2006-09-05 AU AU2006289289A patent/AU2006289289B2/en not_active Ceased
- 2006-09-05 BR BRPI0615466-2A patent/BRPI0615466A2/pt not_active IP Right Cessation
- 2006-09-05 AT AT06777167T patent/ATE494303T1/de active
- 2006-09-05 UA UAA201111468A patent/UA105210C2/ru unknown
- 2006-09-05 NZ NZ565956A patent/NZ565956A/en not_active IP Right Cessation
-
2008
- 2008-04-04 NO NO20081690A patent/NO20081690L/no not_active Application Discontinuation
-
2009
- 2009-10-08 CY CY20091101040T patent/CY1110536T1/el unknown
-
2011
- 2011-03-11 CY CY20111100271T patent/CY1113062T1/el unknown
- 2011-04-04 HR HR20110240T patent/HRP20110240T1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20081690L (no) | Tumorassosierte peptider som bindes til humant leukocyttantigen (HLA) klasse I- eller II-molekyler og relatert vaksine mot kreft | |
| HK1220709A1 (zh) | 混雜地結合於人類白細胞抗原 類分子的腫瘤相關肽 | |
| PL1794190T3 (pl) | Immunogenne epitopy komórek pomocniczych T pochodzące z ludzkich antygenów nowotworowych oraz sposoby stosowania tych epitopów w immunoterapii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |